Fri Jun 24, 2005
The UCSF School of Pharmacy was the largest recipient of 2004 research funding from the National Institutes of Health (NIH) among pharmacy schools in the United States. The School's 2004 total NIH award funding was US$23.5 million.
Fri Mar 11, 2005
UCSF School of Pharmacy scientist Christopher A. Voigt, PhD is a 2005 recipient of the prestigious Sloan Research Fellowship awarded by the Alfred P. Sloan Foundation.
Fri Nov 5, 2004
Thinking like engineers has transformed a new wave of UCSF scientists into systems experts who use big computers and big technology to ask the biggest question of all: How does life work? A new field called systems biology looks at how all components of biological systems work together.
Tue Mar 9, 2004
UCSF School of Pharmacy scientist Matthew P. Jacobson, PhD is the new recipient of a prestigious Sloan Research Fellowship awarded by the Alfred P. Sloan Foundation.
Tue Mar 9, 2004
Some people see a future populated by billions of mechanical micromachines, robots no bigger than a speck of dust that are programmed to do our bidding. UCSF School of Pharmacy researcher Christopher Voigt, PhD sees a different future. He sees living micromachines that can be engineered into a new...
Mon Jan 5, 2004
By early spring 2004, five female scientists from the UCSF School of Pharmacy will have moved to Mission Bay, the University of California San Francisco's new 43-acre research campus.
Wed Jul 9, 2003
The UCSF School of Pharmacy will establish its first distinguished professorship following a gift from one of its most illustrious alums. Harry Wm. Hind—inventor of both the Lidoderm® patch and the wetting solution that helped bring contact lenses into widespread use—and his wife, Diana V. Hind,...
Fri Apr 4, 2003
Irwin (Tack) D. Kuntz, PhD, professor, Department of Pharmaceutical Chemistry, UCSF School of Pharmacy has been named the 2003 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy (AACP).
Thu Mar 6, 2003
UCSF faculty members voted last December 52% to 48% to no longer accept funds from manufacturers of tobacco products or their subsidiaries. Those in favor of the ban argued that UCSF must oppose tobacco industry funding of academia since the health sciences campus is a leader in tobacco control...
Thu Jan 2, 2003
Tom James, PhD, chair of the department of pharmaceutical chemistry, UCSF School of Pharmacy, is looking for new drug models that act directly on RNA rather than protein, where most drug work is now being done. Why? See UCSF Magazine, "X is for Marking the Spot," August 2002.
